Mr. Dane Bedward is an angel investor and entrepreneur. As an angel investor he has invested in MedTech and health ventures in Canada and the US. Dane is the CEO of NeuroBot Inc., a strategic advisory firm to biopharmaceutical and MedTech companies to assist them with business model generation, strategic planning, corporate structure, and commercialization.
Prior to founding his company, Dane was Senior Vice President International for Genzyme Corporation, a biotech company with revenues of $4.5B prior to being sold to Sanofi-Aventis. Throughout his career Mr. Bedward has worked with other organizations such as Nordion International, Johnson and Johnson (in Canada and Europe), Flow Laboratories, and McMaster University.
Dane serves on the Board of Directors of the Capital Angel Network, and the Board of Governors for the University of Ottawa, as well as chairs the Business Advisory Board of Spiderwort. He is also an Entrepreneur in Residence at Invest Ottawa, an Executive Fellow with Mistral Venture Partners, a member of the Selection Committee of the Ontario Venture Scale-up Program, a Charter Member of TiE and a co-founder of Spiderwort Inc. Dane has previously served on the following Boards: Board of Trustees for Bridgewater State University, The National Medical Devices Alliance, The Ottawa Health and Life Sciences Cluster, The New England-Canada Business Council, The Boston Philharmonic Orchestra, The New England-Latin America Business Council, The Ottawa Life Sciences Council, and the Board of Directors for NeuroBiotec.